Mr. H. Thomas Watkins serves as Independent Chairman of the Company. Mr. Watkins served as the President and Chief Executive Officer of Human Genome Sciences, Inc. and as a member of its board of directors from 2004 until August …
If you want a Stock Review on VNDA, VSTM, XLRN, or ZLAB then come over to http://dailystocktracker.com/register/ …
The Piper Jaffray price target for the stock is $26, and the consensus target is higher at $31. Repros closed Wednesday at $21.83. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is running radio spots for its non 24 drug, Tasimelteon. New …
Many investors like to look for momentum in stocks, but this can be very tough to define. There is great debate …
If the stock closes at or above $13 at expiration this trade will return 7.41% or 16.55% (for comparison purposes only). VNDA closed Dec 29, 2017's trading session at $15.16. In the past year, the stock has hit a 52-week low of $11.90 and …
Vanda Pharmaceuticals Inc. (VNDA) announced after the close Thursday that it has ... Vanda Pharmaceuticals gapped up Friday and climbed during the first hour of trade. The stock took out the session highs in late trade and closed up by …
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) 31.2% HIGHER; announced that the U.S. Food and ... announced the …
WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $604,000 in its fourth quarter. The Washington-based company said it had a loss of 1 cent per share. Earnings, adjusted for amortization …
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), a biopharmaceutical company ... Naked short selling is the illegal act …